Combination chemotherapy (M 2 protocol) of Waldenstrom's macroglobulinemia with melphalan, cyclophosphamide, vincristine, and BCNU (1,3 bis(2 chlorethyl) 1 nitrosourea, (M 2 protocol)

Z. Arlin; B. J. Lee; B. Clarkson

Combination chemotherapy (M 2 protocol) of Waldenstrom's macroglobulinemia with melphalan, cyclophosphamide, vincristine, and BCNU (1,3 bis(2 chlorethyl) 1 nitrosourea, (M 2 protocol)

Z. Arlin
, B. J. Lee
, B. Clarkson

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	No.C 283
Journal	Proceedings of the American Association for Cancer Research
Volume	Vol.18
State	Published - 1977
Externally published	Yes

Cite this

@article{cb4f67f130df46efba046fb5ab9c25a6,

title = "Combination chemotherapy (M 2 protocol) of Waldenstrom's macroglobulinemia with melphalan, cyclophosphamide, vincristine, and BCNU (1,3 bis(2 chlorethyl) 1 nitrosourea, (M 2 protocol)",

author = "Z. Arlin and Lee, \{B. J.\} and B. Clarkson",

year = "1977",

language = "English",

volume = "Vol.18",

pages = "No.C 283",

journal = "Proceedings of the American Association for Cancer Research",

}

Combination chemotherapy (M 2 protocol) of Waldenstrom's macroglobulinemia with melphalan, cyclophosphamide, vincristine, and BCNU (1,3 bis(2 chlorethyl) 1 nitrosourea, (M 2 protocol). / Arlin, Z.; Lee, B. J.; Clarkson, B.
In: Proceedings of the American Association for Cancer Research, Vol. Vol.18, 1977, p. No.C 283.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Combination chemotherapy (M 2 protocol) of Waldenstrom's macroglobulinemia with melphalan, cyclophosphamide, vincristine, and BCNU (1,3 bis(2 chlorethyl) 1 nitrosourea, (M 2 protocol)

AU - Arlin, Z.

AU - Lee, B. J.

AU - Clarkson, B.

PY - 1977

Y1 - 1977

UR - https://www.scopus.com/pages/publications/0017392245

M3 - Article

AN - SCOPUS:0017392245

VL - Vol.18

SP - No.C 283

JO - Proceedings of the American Association for Cancer Research

JF - Proceedings of the American Association for Cancer Research

ER -